SCHEMBL7701855

SCHEMBL7701855

O=C(NCc1ccncc1)Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 10/20 0.64
CDK2 P24941 2/20 0.60
CDK1 P06493 1/20 0.60
CHEK1 O14757 3/20 0.58
SGK1 O00141 1/20 0.58
CHEK2 O96017 1/20 0.58
PRKCG P05129 1/20 0.58
AKT1 P31749 1/20 0.58
AKT2 P31751 1/20 0.58
MARK2 Q7KZI7 1/20 0.58
AKT3 Q9Y243 1/20 0.58
ROCK2 O75116 1/20 0.54
ROCK1 Q13464 1/20 0.54
KDR P35968 2/20 0.52
HTT P42858 1/20 0.52
NPC1 O15118 1/20 0.49
CCNE2 O96020 1/20 0.49
CDK4 P11802 1/20 0.49
CCND1 P24385 1/20 0.49
CCNE1 P24864 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7698769 0.93 KDR (0.58) NAMPTCDK2CDK1CHEK1SGK1
SCHEMBL7701559 0.90 NAMPT (0.52) NAMPTCDK2CDK1CHEK1KDR
SCHEMBL7705692 0.86 CHEK1 (0.62) CDK2CDK1CHEK1KDRHTT
SCHEMBL7089915 0.84 CHEK1 (0.68) CDK2CDK1CHEK1SGK1CHEK2
SCHEMBL7701963 0.84 CHEK1 (0.57) CDK2CDK1CHEK1KDR
SCHEMBL7701135 0.83 KMT2A (0.53) CHEK1NPC1
SCHEMBL7702362 0.83 KDR (0.52) NAMPTCDK2CDK1CHEK1KDR
SCHEMBL7092553 0.81 CDK1 (0.71) CDK2CDK1CHEK1SGK1CHEK2
SCHEMBL7002081 0.81 CDK1 (0.67) CDK2CDK1CHEK1SGK1CHEK2
SCHEMBL7701122 0.81 CHEK1 (0.48) NAMPTCDK2CDK1CHEK1SGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed